Fatty acid treatment to reduce calcium excretion
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 7, 1994
Issued Date -
N/A
app pub date -
Apr 22, 1993
filing date -
Jun 5, 1991
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Reduction of urinary calcium excretion in humans or animals by the administration of GLA or DGLA as much or in salt or other pharmacologically acceptable form, optionally in association with EPA, DHA or other EFA in similar forms, is also useful in the treatment of nephrocalcinosis, renal stones and osteoporosis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully